Virtual Docking, design and in silico ADMET profiling of novel Rho-associated protein kinases-1 (ROCK1) inhibitors

Authors:
  • JRJelena Rebić
    Jelena Rebić
  • MRMilica Radan
    Milica Radan
  • TĐTeodora Đikić
    Teodora Đikić
  • SOSlavica Oljačić
    Slavica Oljačić
  • KNKatarina Nikolic
    Katarina Nikolic
  • UTUniversité de Strasbourg Laboratoire D’innovation Thérapeutique
    Université de Strasbourg Laboratoire D’innovation Thérapeutique

Abstract
No abstract available